Seeing Is Believing
EVAX is currently covered by 1 analysts with an average price target of $9.63. This is a potential upside of $5.45 (130.38%) from yesterday's end of day stock price of $4.18.
Evaxion Biotech AS's activity chart (see below) currently has 1 price targets and 3 ratings on display. The stock rating distribution of EVAX is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 50% with an average time for these price targets to be met of 281 days.
Highest price target for EVAX is $2, Lowest price target is $1, average price target is $9.63.
Most recent stock forecast was given by THOMAS FLATEN from LAKE STREET on 18-Apr-2023. First documented stock forecast 30-Jul-2021.
Currently out of the existing stock ratings of EVAX, 2 are a BUY (100%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
7
$2.87 (69.49%)
1 years 10 days ago
1/2 (50%)
$5.45 (351.61%)
281
What is EVAX (Evaxion Biotech AS) average time for price targets to be met?
Which analyst has the current highest performing score on EVAX (Evaxion Biotech AS) with a proven track record?
Which analyst has the most public recommendations on EVAX (Evaxion Biotech AS)?
Which analyst is the currently most bullish on EVAX (Evaxion Biotech AS)?